NeuroBo Pharmaceuticals, Inc. (NRBO)
NASDAQ: NRBO · Real-Time Price · USD
2.350
-0.010 (-0.42%)
Nov 21, 2024, 3:59 PM EST - Market closed
NeuroBo Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Cash & Equivalents | 21.67 | 22.44 | 33.36 | 16.39 | 10.09 | 13.91 | Upgrade
|
| Cash & Short-Term Investments | 21.68 | 22.44 | 33.36 | 16.39 | 10.09 | 13.91 | Upgrade
|
| Cash Growth | -16.09% | -32.76% | 103.60% | 62.42% | -27.46% | 388.86% | Upgrade
|
| Prepaid Expenses | 0.25 | 0.01 | - | 0.2 | 0.55 | 0.15 | Upgrade
|
| Restricted Cash | - | - | - | - | - | 0.02 | Upgrade
|
| Other Current Assets | - | 0.06 | 0.17 | - | 0.05 | 0.04 | Upgrade
|
| Total Current Assets | 21.94 | 22.51 | 33.53 | 16.58 | 10.68 | 14.12 | Upgrade
|
| Property, Plant & Equipment | 0.19 | 0.25 | 0 | 0.22 | 0.29 | 0.35 | Upgrade
|
| Other Long-Term Assets | 0.02 | 0.02 | - | - | - | - | Upgrade
|
| Total Assets | 22.15 | 22.78 | 33.53 | 16.8 | 10.97 | 14.47 | Upgrade
|
| Accounts Payable | 1.02 | 0.82 | 0.71 | 0.83 | 2.58 | 0.64 | Upgrade
|
| Accrued Expenses | 7.44 | 4.41 | 0.28 | 1.3 | 1.1 | 1.42 | Upgrade
|
| Current Portion of Leases | 0.08 | 0.07 | - | 0.03 | 0.02 | 0.02 | Upgrade
|
| Other Current Liabilities | 0.58 | 0.66 | 10.8 | - | - | - | Upgrade
|
| Total Current Liabilities | 9.11 | 5.96 | 11.78 | 2.16 | 3.7 | 2.08 | Upgrade
|
| Long-Term Leases | 0.08 | 0.14 | - | 0.05 | 0.07 | 0.09 | Upgrade
|
| Total Liabilities | 9.19 | 6.1 | 11.78 | 2.2 | 3.77 | 2.18 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.03 | 0 | 0.02 | 0.02 | Upgrade
|
| Additional Paid-In Capital | 143.63 | 124.95 | 117.52 | 96.42 | 73.71 | 49.13 | Upgrade
|
| Retained Earnings | -130.68 | -108.27 | -95.8 | -81.83 | -66.54 | -36.87 | Upgrade
|
| Comprehensive Income & Other | - | - | - | 0 | 0.01 | 0.01 | Upgrade
|
| Total Common Equity | 12.95 | 16.69 | 21.75 | 14.6 | 7.2 | 12.29 | Upgrade
|
| Shareholders' Equity | 12.95 | 16.69 | 21.75 | 14.6 | 7.2 | 12.29 | Upgrade
|
| Total Liabilities & Equity | 22.15 | 22.78 | 33.53 | 16.8 | 10.97 | 14.47 | Upgrade
|
| Total Debt | 0.15 | 0.2 | - | 0.07 | 0.09 | 0.12 | Upgrade
|
| Net Cash (Debt) | 21.53 | 22.23 | 33.36 | 16.32 | 10 | 13.79 | Upgrade
|
| Net Cash Growth | -15.97% | -33.37% | 104.49% | 63.24% | -27.53% | 410.06% | Upgrade
|
| Net Cash Per Share | 3.33 | 4.38 | 103.71 | 169.20 | 147.92 | 633.62 | Upgrade
|
| Filing Date Shares Outstanding | 8.62 | 4.91 | 3.4 | 0.11 | 0.09 | 0.07 | Upgrade
|
| Total Common Shares Outstanding | 8.61 | 4.91 | 3.18 | 0.11 | 0.08 | 0.06 | Upgrade
|
| Working Capital | 12.82 | 16.55 | 21.75 | 14.43 | 6.99 | 12.04 | Upgrade
|
| Book Value Per Share | 1.50 | 3.40 | 6.84 | 131.40 | 87.88 | 189.20 | Upgrade
|
| Tangible Book Value | 12.95 | 16.69 | 21.75 | 14.6 | 7.2 | 12.29 | Upgrade
|
| Tangible Book Value Per Share | 1.50 | 3.40 | 6.84 | 131.40 | 87.88 | 189.20 | Upgrade
|
| Machinery | 0.09 | 0.08 | 0.03 | 0.22 | 0.22 | 0.22 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.